Literature DB >> 29229273

Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages.

Ana Costa1, Bruno Sarmento2, Vítor Seabra3.   

Abstract

Mannose receptor is highly expressed on alveolar macrophages, being a potential target to promote the specific local drug delivery of anti-tuberculosis agents through the use of functionalized nanocarriers. In this work, isoniazid (Isn)-loaded solid lipid nanoparticles (SLN), reinforced with stearylamine (SA) were produced by double emulsion technique and further surface-functionalized with mannose in a straightforward chemical approach. Upon pre-formulation assessment, SLN close to 500 nm average size, positively charged and with association efficiency of ISN close to 50% were obtained. Functionalization with mannose was performed after SLN production and confirmed by Fourier transform infrared spectroscopy (FTIR). Both functionalized and non-functionalized SLN demonstrated to devoid of toxicity when tested in human lung epithelial cell line (NCI-H441) and differentiated THP-1 (dTHP-1), reducing the intrinsic cytotoxicity of Isn when incorporated into SLN. Uptake studies were conducted on same macrophage-like cells and the results showed that fluorescent mannosylated SLN (M-SLN) were more efficient in be internalized comparatively to SLN. Moreover, the uptake of M-SLN was reduced when cells were pre-incubated with mannose, demonstrating the receptor-dependence internalization of functionalized SLN. These functionalized nanocarriers may represent a useful platform to target alveolar macrophages for delivering anti-infective drugs.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alveolar macrophage; Macrophage nanoparticle uptake; Mannose functionalization; Solid lipid nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 29229273     DOI: 10.1016/j.ejps.2017.12.006

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  22 in total

Review 1.  Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead.

Authors:  Estefania Grotz; Nancy Tateosian; Nicolas Amiano; Maximiliano Cagel; Ezequiel Bernabeu; Diego A Chiappetta; Marcela A Moretton
Journal:  Pharm Res       Date:  2018-09-20       Impact factor: 4.200

Review 2.  Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review).

Authors:  Olga V Zhukova; Tatiana F Kovaleva; Evgenia V Arkhipova; Sergey A Ryabov; Irina V Mukhina
Journal:  Biomed Rep       Date:  2020-08-28

Review 3.  Mesoporous silica nanocarriers as drug delivery systems for anti-tubercular agents: a review.

Authors:  Josephine Oluwagbemisola Tella; Joseph Adeyemi Adekoya; Kolawole Oluseyi Ajanaku
Journal:  R Soc Open Sci       Date:  2022-06-08       Impact factor: 3.653

Review 4.  Nanotechnology for angiogenesis: opportunities and challenges.

Authors:  Saeid Kargozar; Francesco Baino; Sepideh Hamzehlou; Michael R Hamblin; Masoud Mozafari
Journal:  Chem Soc Rev       Date:  2020-06-15       Impact factor: 54.564

5.  Nanoparticle-mediated macrophage targeting-a new inhalation therapy tackling tuberculosis.

Authors:  Shaimaa Makled; Nabila Boraie; Noha Nafee
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

6.  Mannosylated Cationic Copolymers for Gene Delivery to Macrophages.

Authors:  Anton V Lopukhov; Zigang Yang; Matthew J Haney; Tatiana K Bronich; Marina Sokolsky-Papkov; Elena V Batrakova; Natalia L Klyachko; Alexander V Kabanov
Journal:  Macromol Biosci       Date:  2021-02-22       Impact factor: 4.979

7.  Strengthening peptide-based drug activity with novel glyconanoparticle.

Authors:  Jordan D Lewicky; Alexandrine L Martel; Nya L Fraleigh; Amanda Boraman; Thi M-D Nguyen; Peter W Schiller; Tze Chieh Shiao; René Roy; Hoang-Thanh Le
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

Review 8.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

Review 9.  Multivalent nanosystems: targeting monocytes/macrophages.

Authors:  Rémy Poupot; Cécile Goursat; Séverine Fruchon
Journal:  Int J Nanomedicine       Date:  2018-09-19

Review 10.  Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention.

Authors:  Bushra Nabi; Saleha Rehman; Sumit Aggarwal; Sanjula Baboota; Javed Ali
Journal:  Drug Deliv Transl Res       Date:  2020-08       Impact factor: 5.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.